• English
    • Latviešu
    • Deutsch
    • русский
  • Help
  • English 
    • English
    • Latviešu
    • Deutsch
    • русский
  • Login
View Item 
  •   DSpace Home
  • B6 – LU institūti un aģentūras / Institutes and agencies of the UL
  • Cietvielu fizikas institūts / Institute of Solid State Physics
  • Zinātniskie raksti (CFI) / Scientific articles
  • View Item
  •   DSpace Home
  • B6 – LU institūti un aģentūras / Institutes and agencies of the UL
  • Cietvielu fizikas institūts / Institute of Solid State Physics
  • Zinātniskie raksti (CFI) / Scientific articles
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Personalized PDAC chip with functional endothelial barrier for tumour biomarker detection: A platform for precision medicine applications

Thumbnail
View/Open
Article (7.135Mb)
Author
Goluba, Karina
Parfejevs, Vadims
Rostoka, Evita
Jekabsons, Kaspars
Blake, Ilze
Neimane, Anastasija
Ule, Annija Anete
Rimsa, Roberts
Vangravs, Reinis
Pcolkins, Andrejs
Riekstina, Una
Date
2024
Metadata
Show full item record
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer characterised by poor survival rates and an increasing global incidence. Advances in the staging and categorization of pancreatic tumours, along with the discovery of functional mutations, have made precision treatments possible, which may lead to better clinical results. To further improve customized treatment approaches, in vitro models that can be used for functional drug sensitivity testing and precisely mimic the disease at the organ level are required. In this study, we present a workflow for creating a personalized PDAC chip utilising primary tumour-derived human pancreatic organoids (hPOs) and Human Umbilical Vein Endothelial Cells (HUVECs) to simulate the vascular barrier and tumour interactions within a PDMS-free organ-on-a-chip system. The patient PDAC tissue, expanded as tumour hPOs, could be cultured as adherent cells on the chip for more than 50 days, allowing continuous monitoring of cell viability through outflows from tumour and endothelial channels. Our findings demonstrate a gradual increase in cell density and cell turnover in the pancreatic tumor channel. Tumour-specific biomarkers, including CA-19.9, TIMP-1, Osteopontin, MIC-1, ICAM-1 and sAXL were consistently detected in the PDAC chip outflows. Comparative analyses between tissue culture plates and microfluidic conditions revealed significant differences in biomarker secretion patterns, highlighting the advantages of the microfluidics approach. This PDAC chip provides a stable, reproducible tumour model system with a functional endothelial cell barrier, suitable for drug sensitivity and secretory biomarker studies, thus serving as a platform for functional precision medicine application and multi-organ chip development. © 2024 The Authors --//-- This is an open-access article Karina Goluba, Vadims Parfejevs, Evita Rostoka, Kaspars Jekabsons, Ilze Blake, Anastasija Neimane, Annija Anete Ule, Roberts Rimsa, Reinis Vangravs, Andrejs Pcolkins, Una Riekstina, Personalized PDAC chip with functional endothelial barrier for tumour biomarker detection: A platform for precision medicine applications, Materials Today Bio, Volume 29, 2024, 101262, ISSN 2590-0064, https://doi.org/10.1016/j.mtbio.2024.101262 published under the CC BY-NC-ND licence.
URI
https://www.sciencedirect.com/science/article/pii/S2590006424003235
https://dspace.lu.lv/dspace/handle/7/67243
DOI
10.1016/j.mtbio.2024.101262
Collections
  • Zinātniskie raksti (CFI) / Scientific articles [604]

University of Latvia
Contact Us | Send Feedback
Theme by 
@mire NV
 

 

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

Login

Statistics

View Usage Statistics

University of Latvia
Contact Us | Send Feedback
Theme by 
@mire NV